@gregory_ms@mastodon.social
Multiple Sclerosis Research powered by GregoryAi
Stem Cell Res Ther. Ther. 2025 Aug 21;16(1):447. The study investigated the synergistic effects of constraint-induced movement therapy (CIMT) and human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation on the motor recovery of rats with hemiplegic cerebral palsy.
Word on LinkedIn: New drug going into stage 2 . It's called Dioprotectome and it's done by NeuOrphan. I checked, and there are no papers or trials on @gregory_ms Can someone help or point me in the right direction?
Elk is a nimble Mastodon web client. You can login to your Mastodon account and use it to interact with the fediverse.
Expect some bugs and missing features here and there. Elk is Open Source and we're actively improving it as a community project. Join us and let's build it together!
If you'd like to report a bug, help us testing, give feedback, or contribute, reach out to us on GitHub and get involved.
To boost development, you can sponsor the Team through GitHub Sponsors. We hope you enjoy Elk!
